OPT - Opthea Ltd. Debt to Book Capitalization Ratio

Opthea Limited relies on a risky single-product model dependent on the test results of a single drug. Synergy with global laboratories is accelerating the market launch of sozinibercept. The total debt-to-market capitalization ratio reflects the dynamics of the liability structure, where the 0.00 indicator determines the magnitude of the metric. Management is focused on completing Phase 3 trials to update the standards of therapy for macular dystrophy.

Opthea Limited is advancing ophthalmological pharmaceuticals through partnerships to test the sozinibercept molecule. The financial stability of such projects is reflected in the debt-to-equity ratio. This coefficient measures the level of debt load relative to the book value of assets. It allows for an assessment of the risks of overpaying or undervaluing a business during M&A. By analyzing the percentage of debt to book capitalization, an investor determines the company's degree of financial leverage.